INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
SEC FORM 4/Tax withholdingVerified data

Wai Conrad reported CLOV

CEO, Counterpart Health · CLOVER HEALTH INVESTMENTS, CORP. /DE · Class A Common Stock

Side
F
Value
$266K
Shares
98.4K
Price
$2.7
Executed
Dec 14, 2025
Disclosed
Dec 16, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Dec 14 executedDec 16, 2025 disclosed

CLOV · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
19/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Tax withholding — administrative, little informational value

  • Relative size+11 / 25

$266K reported value · 10.3% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · CLOV

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    19
    SK
    Soares KarenChief Legal Officer
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$90K
    19.3K sh
    		Oct 20, 2026Oct 20, 2026
    traded Oct 20, 2026
    		+0dSEC FORM 4

    Evidence

    13
    RL
    Reynoso Jamie L.CEO, Medicare Advantage
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$18K
    4,066 sh
    		Oct 19, 2026Oct 20, 2026
    traded Oct 19, 2026
    		+1dSEC FORM 4

    Evidence

    19
    SK
    Soares KarenChief Legal Officer
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$69K
    14.7K sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    20
    TC
    Thornton Joseph ClayInterim CFO
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$21K
    4,591 sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    16
    RL
    Reynoso Jamie L.CEO, Medicare Advantage
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$86K
    18.3K sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    22
    TA
    Toy AndrewDirector, Chief Executive Officer
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$291K
    62.2K sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    19
    WC
    Wai ConradCEO, Counterpart Health
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$111K
    23.6K sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    13
    RL
    Reynoso Jamie L.CEO, Medicare Advantage
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$9,288
    2,006 sh
    		Oct 7, 2026Oct 7, 2026
    traded Oct 7, 2026
    		+0dSEC FORM 4

    Evidence

    13
    RL
    Reynoso Jamie L.CEO, Medicare Advantage
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$8,760
    1,921 sh
    		Sep 17, 2026Sep 18, 2026
    traded Sep 17, 2026
    		+1dSEC FORM 4

    Evidence

    33
    WC
    Wai ConradCEO, Counterpart Health
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$1.42M
    300.0K sh
    		Sep 15, 2026Sep 16, 2026
    traded Sep 15, 2026
    		+1dSEC FORM 4

    Evidence

    20
    SK
    Soares KarenChief Legal Officer
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$33K
    6,846 sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    13
    RL
    Reynoso Jamie L.CEO, Medicare Advantage
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$44K
    9,273 sh
    		Sep 15, 2026Sep 15, 2026
    traded Sep 15, 2026
    		+0dSEC FORM 4

    Evidence

    43
    OF
    Oldakowski Joseph FrankVP OF FINANCE AND CONTROLLER
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale
    		SELL$103K
    20.0K sh
    		Sep 14, 2026Sep 14, 2026
    traded Sep 14, 2026
    		+0dSEC FORM 4

    Evidence

    9
    TC
    Thornton Joseph ClayInterim CFO
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Grant or award
    		A—
    54.3K sh
    		Aug 12, 2026Aug 13, 2026
    traded Aug 12, 2026
    		+1dSEC FORM 4

    Evidence

    13
    SK
    Soares KarenChief Legal Officer
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Grant or award
    		A—
    108.7K sh
    		Aug 12, 2026Aug 13, 2026
    traded Aug 12, 2026
    		+1dSEC FORM 4

    Evidence

    11
    TA
    Toy AndrewDirector, Chief Executive Officer
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$408K
    87.8K sh
    		Aug 10, 2026Aug 10, 2026
    traded Aug 10, 2026
    		+0dSEC FORM 4

    Evidence

    1
    RL
    Reynoso Jamie L.CEO, Medicare Advantage
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$11K
    2,360 sh
    		Jun 17, 2026Jun 18, 2026
    traded Jun 17, 2026
    		+1dSEC FORM 4

    Evidence

    6
    RL
    Reynoso Jamie L.CEO, Medicare Advantage
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$36K
    7,289 sh
    		Jun 11, 2026Jun 11, 2026
    traded Jun 11, 2026
    		+0dSEC FORM 4

    Evidence

    20
    WC
    Wai ConradCEO, Counterpart Health
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale · 10b5-1 plan
    		SELL$879K
    220.4K sh
    		May 28, 2026May 28, 2026
    traded May 28, 2026
    		+0dSEC FORM 4

    Evidence

    23
    PP
    Priest Brady PatrickCEO of Clover Care Services
    CLOVCLOVER HEALTH INVESTMENTS, CORP. /DE
    Open-market sale
    		SELL$345K
    98.0K sh
    		May 13, 2026May 13, 2026
    traded May 13, 2026
    		+0dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001971702-25-000011
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Dec 14, 2025
    Published
    Dec 16, 2025
    Ingested by INSIDER
    Nov 5, 04:27 UTC
    Last re-read
    Nov 5, 04:27 UTC

    Extracted facts

    Filer
    Wai Conrad
    Role
    CEO, Counterpart Health
    Transaction
    Tax withholdingAs filed: “F”
    Asset
    CLOVER HEALTH INVESTMENTS, CORP. /DE
    Ticker
    CLOV
    Shares
    98.4K
    Price per share
    $2.7
    Value
    $265,710
    Execution date (reported)
    Dec 14, 2025
    Owned after transaction
    1.05M shares
    Days from execution to publication
    2

    Calculation

    Value = shares × reported price per share

    • Shares: 98.4K
    • Price: $2.7

    = $265,710

    What this establishes

    Wai Conrad filed this Form 4 reporting a tax withholding of CLOV on Dec 14, 2025. It became public on Dec 16, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    CEO, Counterpart Health
    Wai Conradcik:0001971702
    Issuer
    CLOVER HEALTH INVESTMENTS, CORP. /DEcik:0001801170

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.